Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

Review of 5 RCTs (n=1,713) found moderate‐certainty evidence that there is little or no difference in primary survival outcomes between primary debulking surgery and neoadjuvant chemotherapy (NACT), though NACT may reduce the risk of serious adverse events

Source:

Cochrane Database of Systematic Reviews